---
schema_version: "secwatch.filing_event.v1"
accession: "0001393905-24-000378"
form_type: "8-K"
ticker: "STME"
cik: "0001493712"
company_name: "Stimcell Energetics Inc."
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:18:09.504811+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Cell MedX completes 1:15 reverse stock split and rebrands as Stimcell Energetics

## Summary
- Reverse split 1:15 effective Nov 1, 2024; shares outstanding reduced from ~297M to ~19.8M.
- Authorized capital reduced from 7.5B to 500M shares of common, par value $0.001.
- Name changed from Cell MedX Corp. to Stimcell Energetics Inc.
- Symbol will trade as "CMXCD" for 20 business days starting Nov 5, then seek new symbol.
- New website launched at www.StimCell.com for investor and clinical trial info.

## SEC filing metadata
- accession: 0001393905-24-000378
- form_type: 8-K
- ticker: STME
- cik: 0001493712
- company_name: Stimcell Energetics Inc.
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1493712/000139390524000378/0001393905-24-000378-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1493712/000139390524000378/cmxc-20241101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001393905-24-000378
- JSON: https://secwatch.observer/filing/0001393905-24-000378.json
- Plain text: https://secwatch.observer/filing/0001393905-24-000378.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.